TELA Bio, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
TELA Bio, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2018 to Q3 2024.
  • TELA Bio, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$10.4M, a 5.34% increase year-over-year.
  • TELA Bio, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$41.5M, a 5.1% increase year-over-year.
  • TELA Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$46.7M, a 5.35% decline from 2022.
  • TELA Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$44.3M, a 33.1% decline from 2021.
  • TELA Bio, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$33.3M, a 15.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$41.5M -$10.4M +$585K +5.34% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$42.1M -$12.6M -$1.81M -16.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$40.3M -$5.66M +$6.37M +52.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$46.7M -$12.9M -$2.91M -29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$43.8M -$11M -$243K -2.27% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$43.5M -$10.8M +$1.95M +15.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$45.5M -$12M -$1.17M -10.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$44.3M -$9.98M -$1.36M -15.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$42.9M -$10.7M -$2.45M -29.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$40.5M -$12.7M -$4.49M -54.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$36M -$10.9M -$2.73M -33.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$33.3M -$8.62M -$829K -10.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-22
Q3 2021 -$32.4M -$8.27M -$563K -7.31% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$31.9M -$8.26M -$2.17M -35.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$29.7M -$8.14M -$916K -12.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$28.8M -$7.79M -$1.26M -19.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 -$27.5M -$7.7M -$3.04M -65.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$24.5M -$6.08M -$820K -15.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$23.7M -$7.22M -$1.25M -21% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$22.4M -$6.53M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-23
Q3 2019 -$4.67M -$1.86M -66.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.26M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$5.97M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 -$2.81M Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.